ESPR — ESPERION THERAPEUTICS INC NE

Ownership history in ORBIMED ADVISORS LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.67% (2024 Q1)
Avg. % of fund
0.38%
First filed
2013 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 5,965,498 -7,743,233 -56.5% 0.45% $22.1M $3.70
2024 Q1 ADDED 13,708,731 +13,647,931 +22447.3% 0.67% $36.7M $2.68
2013 Q3 INITIATED 60,800 — — 0.02% $1.1M $18.86
% of Fund (quarterly)    ESPR price (monthly, adj. close)

Other funds also holding ESPR

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 3.58% Velan Capital Investment Management LP 3Y 2.6% PenderFund Capital Management Ltd. 3Y 7Y 2.56% Two Seas Capital LP 3Y 0.91% Eversept Partners, LP 3Y 7Y 0.72% nVerses Capital, LLC 0.56% Summit Wealth Group, LLC 3Y 0.29% WASATCH ADVISORS LP 3Y 7Y 0.21% Virtus Investment Advisers, LLC 3Y 7Y 0.18% Diametric Capital, LP 3Y 7Y 0.17%
← Back to ORBIMED ADVISORS LLC Holdings